Medi Assist Healthcare Services Limited IPO Message Board (Page 20)

Fantastic anchor book.
0 debt, decent growth in top & bottom line.
Also cant say PE is high as there are no listed peers!
Most likely will go with Hni apps.

QIB subscribed 90% as of now with FII support. DIIs and MFs are doing the waiting game.

Gmp 30

Current GMP?

Hello, G M P is Rs 36 or 8.6%

You may also check the GMP yourself in CG as well. Just look for GMP link at the top of page.

Today's drastic fall in market with yesterday's fall has led investors in bit doubt about correction in market. After all time high again and again it was expected. Today PSUs and IT Sector has restricted more fall in the market. HDFC Bank is the leader of this fall.
Now, Medi Assist is concerned, full OFS, higher price and equity post IPO is concern. The business model of Third Party Administrator is also not favorable, in my opinion. In addition fall in today's market is going to effect subscription figures. Not good figures till now. Risky with better allotment chances. Better to evaluate at personal level and decide to subscribe.
Any further fall will definitely effect the listing. Market fall already crossed 1000, a concern.
Ally personal views.

Applied
4 bhni
6 sHNI

Final apply or not pls🙏

​@Admin @ Chittorgarh.com 

today, subscription data is not updated here at 10.30 am.....

I think it's updated but not noticeable due to negligible gain.

Will be going FF

They are the clear market leader in the space, health insurance significantly underpenetrated in India, biz has consistent, rapid growth (25%+ YOY), with near-zero customer churn, promoters solid and forward thinking (inorganic growth, global acquisition to drive core India biz rather than vanity of 'global expansion', integrating technology into biz etc.), great operational efficiency (23-24% EBITDA vs unlisted peers at 5-15% EBITDA), no debt.

Only qn is the asking price, since it has no peers. Insurance cos generally trade in the 40-80 PE range depending on subsector. With a PE of 32 on FY24 numbers, and being a unique co, i don't see much risk.

What could be market cap at asking price any idea?

Unable to find anything negative in the biz fundamentals.

1. They are the clear market leader in the space, and with health insurance significantly underpenetrated in India, there's lot of headroom for growth.

2. Biz has consistent, rapid growth (25%+ YOY), faster than the market with near-zero customer churn.

3. Promoters are solid and forward thinking (inorganic growth along with organic, global acquisition to drive core India biz rather than vanity of 'global expansion', integrating technology into biz etc.).

4. Great operational efficiency (23-24% EBITDA compared to unlisted peers with 5-15% EBITDA) with no debt.

Only question is on the asking price, since it has no direct peers. Insurance cos in India generally trade in the 40-80 PE range depending on subsector. With a PE of 32 on FY24 numbers, and being a first-of-its-sector listing in the country, I will go FF

​@ultrasnow Brother what's your view?
Can we take risk here🤔
Peer is PB fintech I think it's going up even though loss making company.
Medi have postive and negetive both

​@BullOverBear Thanks.
In my view they didn't gave good result but promoter assuring they will give best in upcoming and currently some ad and gratuity expanses causing reduction in margin.
He said Q1 and Q3 mostly subdued and Q2 and Q4 are best so Q4 will be good and guidance is flat for FY24 PAT.

Here QoQ revenue is increased but pat is lesser because of extra expenses.

You are right that never trust on concall , they mostly lie to us , so we should decide after our full study only.

This result is not that bad and not as expected also ,
Now future result will decide the fate of credo and me , as of now I'm still holding it in loss.

Here are my observations from the call

1. We did not have any representatives from big investors or fund houses , only angry young men. ( @Seth.  you know what i am saying)
2. Mufti Uncle says the PAT will be flat this year , although revenue might grow.
3. He says he still yet to see demand in this quarter Q4
4. The other investors did not sound very happy on when he said Q3 is a weak quarter.
5. The big question about other brands growing at 20% was avoided with the help of divine intervention( the call moderator)

Medi Assist IPO Verdict

Small Risk Takers can Apply for Small Listing Gains and Short Term

No/Low Risk Takers can Apply for Long-term or Buy Post-listing

I will be posting something completely out of the box

X handle ya koi dusre platform ka id batane par idhar apka id block ho sakta he

Bajaj auto,1share can buy for buyback

Yes, you may buy 1 share of Bajaj Auto, most probably one share is accepted in buyback offers.

I have decided to give this IPO a miss, due to following Reasons :
1. Low QIB allocation compared to Jyoti ( this is not company fault, but this will increase free float in retail and nii hands)
2. Poor HNI figures (this will create hugh selling pressure on listing)
3. High floating stock with retailers 35 percent plus NII 15 percent
4. Not so Free bank balance. I have other option in the form of SME.
5. GMP buyer not available most of the times, even if there is a buyer is at a very petty premium.
6. Complete OFS. In many past OFS, we have already burnt our hands.
7. Relatively large size of the IPO (in comparison to Jyoti)
8. Jyoti was appearing overpriced but it had some x factor., this IPO certainly is overpriced, i dont see any x factor.
9. Startups are not the flavour of season right now.
10. Nifty in correction mode.

Sometimes, listings surprise us either side, but the above reasons are sufficient for me not to apply in this IPO.

I will rather put my funds in sme with low chance of allotment but safe.

Applied full force
Let's hope for best

hoping for positive updates on this one ,,,
and hopefully 10% listing gain

Retail 1/2 , BHNI 0/1 , SHNI 0/1

Premium not going down , good anchor book.

But risk to hai , better to apply half at current premium 40-44 per share on gm.

And take risk of half part

My strategy .

Probably tomorrow good QIB CHANCES .

My gut feeling says

This is a discount listing material.

As such, as of now, I will skip this full OFS.

But final decision tomorrow after seeing QIB subscription.

Sir Iski GMP fake nahi hai abhi premium 45 rs h or buying bhi ho rahi hai is rate p ll

​@Mahaveer Prasad Gupta Ji.. aapki full right hai.. apna view rakhney ka.. Baaki share market achhey achhey expert ko bhi fail kar deti hai.. Jaise aaj Jyoti mai sab expert fail ho gaye.. Don't take otherwise Sir.. All the best 🎄

Jyoti cnc listed almost flat,but closed at 31% premium.May we expect the same for this IPO?
All learned members are advising to buy after listing.I will follow the same. Thanks.

Not sure about listing day behaviour but for 2-3 year Medi is better opportunity than Jyoti

When the consensus is overall positive, allotment isn't easy to come by as everyone applies for sure. When the consensus is divided, that's where real opportunity with applicable risk comes in as when has to take a calculated bet as per appetite to apply or not.

Given the above, IPO now in this stage of market are less of short term view imo, more of what works now is long term view and that brings with it fundamentals of a company. So, final choice is and should be based on risk appetite and fundamental aspect of the company

Allied Blenders Refiles DRHP with SEBI
Issue size now 1500 cr
Fresh - 1000 cr
OFS - 500 cr